A phase I trial of MK-0731, a Kinesin Spindle Protein (KSP) inhibitor, in patients with solid tumors

PURPOSE: The kinesin spindle protein (KSP) is essential for separation of spindle poles during mitosis. Its inhibition results in mitotic arrest. This phase I trial examined safety, tolerability, dose-limiting toxicity (DLT), maximum tolerated dose (MTD), pharmacokinetic parameters, and anti-tumor a...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Holen, Kyle, DiPaola, Robert, Liu, Glenn, Tan, Antoinette R., Wilding, George, Hsu, Karl, Agrawal, Nancy, Chen, Cong, Xue, Lingling, Rosenberg, Elizabeth, Stein, Mark
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3394096/
https://ncbi.nlm.nih.gov/pubmed/21424701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-011-9653-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky